BioSpace News Archive

HLTH, the largest and most important conference for health innovation, announced today a partnership with Boston Children’s Hospital focused on voice technology in health.

The U.S. Food and Drug Administration today approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat.

Healogics® VeinCare aims to partner with existing practices to provide more comprehensive patient care in the outpatient setting

Building on its market-leading efforts in preclinical research aimed at clinical implementation of Flash therapy, Varian hosted the first meeting of the FlashForward™ Consortium in Atlanta, Georgia on March 8-9.

HENRY The Dentist announced the closing of a $10 million Series A financing, led by Forerunner Ventures, to expand its fleet of mobile dental practices to companies in New Jersey, Pennsylvania, Georgia, New York and additional states across the US.

The March issue of United Spinal Association’s New Mobility Magazine features wheelchair-using doctors who have had to contend with medical schools’ outdated technical standards and institutional bias but have nonetheless persevered and succeeded.

GestVision, Inc., a privately-held biotechnology company, applauds the diligent work of the clinical researchers who conducted the first prospective clinical study of a rapid CRD urine diagnostic for confirming or ruling out preeclampsia

Multiple studies and new data clarifying the Addyi and alcohol interaction for both the medical community and patients were formally submitted to the FDA as well as presented to The International Society for the Study of Women’s Sexual Health (ISSWSH), International Society for Sexual Medicine (ISSM) and Sexual Medicine Society of North America (SMSNA).

Highmark Health announced that Saurabh Tripathi has been named Executive Vice President and Chief Financial Officer.

Emerging Drug Enforcement Administration (DEA) rule changes related to the transport and dispensing of controlled substances will have a major impact in the industry